Here's the live share price of Dr. Lal Pathlabs along with daily highs, lows, percentage changes and volume trends, and, all financial information.
Name | 1W(%) | 1M(%) | 3M(%) | 6M(%) | 1Y(%) | 3Y(%) | 5Y(%) |
|---|---|---|---|---|---|---|---|
| Dr. Lal Pathlabs | 3.43 | 15.12 | 10.80 | 3.25 | 12.98 | 15.85 | 2.79 |
| Apollo Hospitals Enterprise | 3.27 | 6.78 | 6.47 | 6.98 | 15.97 | 20.31 | 20.21 |
| Max Healthcare Institute | 1.79 | 6.99 | -4.26 | -7.77 | -12.38 | 26.75 | 35.40 |
| Fortis Healthcare | 0.13 | 11.79 | 2.41 | -1.93 | 40.52 | 52.03 | 32.74 |
| Aster DM Healthcare | -1.78 | 9.57 | 20.93 | 7.08 | 33.11 | 42.32 | 36.19 |
| Narayana Hrudayalaya | 4.39 | 4.01 | -1.28 | 4.50 | 3.25 | 34.16 | 34.94 |
| Global Health | 1.91 | 12.45 | 4.03 | 1.56 | -2.87 | 29.85 | 23.48 |
| Krishna Institute of Medical Sciences | 11.07 | 14.17 | 7.43 | 9.21 | 14.99 | 36.05 | 30.39 |
| Dr. Agarwals Health Care | -0.46 | 4.63 | -1.00 | -11.03 | 23.41 | 4.17 | 2.48 |
| Vijaya Diagnostic Centre | 9.16 | 29.38 | 28.68 | 24.90 | 29.12 | 50.65 | 15.64 |
| Rainbow Childrens Medicare | 2.62 | 1.09 | 6.11 | -4.99 | -4.60 | 14.94 | 23.44 |
| Metropolis Healthcare | 8.30 | 18.56 | 10.46 | 11.15 | 27.95 | 17.40 | -1.52 |
| Park Medi World | 2.03 | 17.05 | 41.55 | 64.77 | 64.77 | 18.11 | 10.50 |
| Healthcare Global Enterprises | -2.84 | 9.29 | 1.65 | -19.17 | 4.86 | 29.82 | 25.83 |
| Jupiter Life Line Hospitals | 0.37 | -1.13 | -1.96 | -17.16 | -13.42 | 4.66 | 2.77 |
| Yatharth Hospital & Trauma Care Services | -0.30 | 8.58 | 17.79 | 10.51 | 69.04 | 34.84 | 19.64 |
| Thyrocare Technologies | 9.90 | 19.87 | 18.31 | 1.91 | 49.68 | 45.16 | 6.68 |
| Kovai Medical Center and Hospital | -3.06 | 0.16 | 0.28 | -10.61 | -4.07 | 39.38 | 32.47 |
| Nephrocare Health Services | 7.83 | 0.29 | 0.54 | 22.74 | 22.74 | 7.07 | 4.18 |
| Artemis Medicare Services | 7.31 | 18.58 | 10.58 | 0.39 | 6.94 | 48.03 | 59.21 |
Over the last one year, Dr. Lal Pathlabs has gained 12.98% compared to peers like Apollo Hospitals Enterprise (15.97%), Max Healthcare Institute (-12.38%), Fortis Healthcare (40.52%). From a 5 year perspective, Dr. Lal Pathlabs has underperformed peers relative to Apollo Hospitals Enterprise (20.21%) and Max Healthcare Institute (35.40%).
| Day | SMA | EMA |
|---|---|---|
| 5 | 1,583.03 | 1,599.2 |
| 10 | 1,491.74 | 1,545.73 |
| 20 | 1,454.7 | 1,488.7 |
| 50 | 1,397.53 | 1,436.77 |
| 100 | 1,410.8 | 1,436.54 |
| 200 | 1,497.89 | 1,451.58 |
In the latest quarter, Dr. Lal Pathlabs remained same as its previous close in promoter holding, while DII stake increased to 21.37%, FII holding fell to 17.18%, and public shareholding moved up to 7.88% compared to the previous quarter — reflecting a shift in investor sentiment across categories.
Fund Name | No. Of Shares | % of AUM | Amount Invested(in ₹ crore) |
|---|---|---|---|
| 41,78,451 | 0.6 | 548.25 | |
| 25,60,250 | 1.64 | 335.93 | |
| 15,16,484 | 0.43 | 198.98 | |
| 13,00,000 | 0.49 | 170.57 | |
| 12,90,970 | 0.27 | 169.39 | |
| 12,18,224 | 2.02 | 159.84 | |
| 11,40,000 | 1.02 | 149.58 | |
| 10,54,917 | 1.16 | 138.42 | |
| 7,77,616 | 1.05 | 102.03 | |
| 7,50,000 | 0.94 | 98.41 |
* Excluding Index & Arbitrage Funds
Date Time | Announcement |
|---|---|
| May 06, 2026, 11:42 PM IST IST | Dr. Lal Pathlabs - Announcement under Regulation 30 (LODR)-Earnings Call Transcript |
| May 02, 2026, 12:48 AM IST IST | Dr. Lal Pathlabs - Announcement under Regulation 30 (LODR)-Updates on Acquisition |
| May 01, 2026, 12:40 AM IST IST | Dr. Lal Pathlabs - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome |
| Apr 30, 2026, 09:40 PM IST IST | Dr. Lal Pathlabs - Announcement under Regulation 30 (LODR)-Investor Presentation |
| Apr 30, 2026, 09:37 PM IST IST | Dr. Lal Pathlabs - Announcement under Regulation 30 (LODR)-Press Release / Media Release |
Dr. Lal Pathlabs Ltd. is a Public Limited Listed company incorporated on 14/02/1995 and has its registered office in the State of Delhi, India. Company's Corporate Identification Number(CIN) is L74899DL1995PLC065388 and registration number is 065388. Currently Company is involved in the business activities of Other human health activities. Company's Total Operating Revenue is Rs. 2647.60 Cr. and Equity Capital is Rs. 167.60 Cr. for the Year ended 31/03/2026.
The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for Dr. Lal Pathlabs is ₹1,589.40 as on May 12, 2026.
The Dr. Lal Pathlabs is operating in the Pharmaceuticals and health care Sector. It is classified as a Midcap stock on the BSE.
The market cap of Dr. Lal Pathlabs is ₹26,644.35 Cr as on May 12, 2026.
Today’s highest and lowest price of Dr. Lal Pathlabs are ₹1,654.35 and ₹1,581.50.
The 52-week high/low is the highest and lowest price at which Dr. Lal Pathlabs stock has traded in the past 52-week or nearly a year. The 52-week high of Dr. Lal Pathlabs is ₹1,771.30 and 52-week low of Dr. Lal Pathlabs is ₹1,272.00 as on May 12, 2026.
The Dr. Lal Pathlabs has shown returns of -3.75% over the past day, 15.12% for the past month, 10.8% over 3 months, 12.98% over 1 year, 15.85% across 3 years, and 2.79% over 5 years.
P/E ratio of and PB ratio of Dr. Lal Pathlabs are 52.78 and 10.40 on May 12, 2026. While the company gives a dividend yield of 0.00 per annum.